Artemether + Lumefantrine Tablets
Artemether 20 mg + Lumefantrine 120 mg
- Dosage Form
- Tablet
- Strength
- 20 mg / 120 mg
- HS Code
- 3004.60
- MOQ
- MOQ on request — tender quantities supported
Target markets: Africa, SE Asia
Try: Paracetamol, Amoxicillin, Dolutegravir, HS code, Africa, RCMC
Artemisinin combination therapies are the mainstay; Global Fund, PMI and UNICEF are the dominant buyers.
Artemisinin-based combination therapies (ACTs) dominate this category, alongside older standards like chloroquine and newer options such as tafenoquine. WHO Prequalification is effectively mandatory to reach the donor-funded procurement channels — Global Fund, the President's Malaria Initiative and UNICEF — that buy the bulk of volume in this class.
Amodiaquine
Arteether
Artemether + Lumefantrine
Artemether injection
Artemisinin
Artemotil
Artesunate + Amodiaquine
Artesunate + Mefloquine
Artesunate + Sulfadoxine-Pyrimethamine
Artesunate injection
Atovaquone + Proguanil
Chloroquine
Chlorproguanil + Dapsone
Clindamycin (adjunct)
Dihydroartemisinin
Dihydroartemisinin + Piperaquine
Doxycycline (prophylaxis)
Halofantrine
Market-specific ban — Banned/withdrawn in several destinations
Hydroxychloroquine
Lumefantrine
Mefloquine
Piperaquine
Primaquine
Proguanil
Pyrimethamine
Pyronaridine + Artesunate
Quinidine
Quinine
Quinine dihydrochloride injection
Rectal artesunate suppository
Sulfadoxine + Pyrimethamine
Sulfalene
Tafenoquine
No molecules match your search.
Showing 33 of 33 molecules tracked in this class. Contact us for a specific molecule not listed here.
Our manufacturing-partner network covers a broad range beyond this catalogue. Send us your requirement.